TickerFacts.

A business in context

HROW research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-04 · 0001493152-26-041569 · Items 5.02,9.01

  2. 4 · Ownership change

    Report date 2026-08-14 · 0001493152-26-038807

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-055271

  4. 8-K · Current report

    Report date 2026-08-10 · 0001493152-26-036865 · Items 2.02,7.01,9.01

  5. 8-K · Current report

    Report date 2026-08-03 · 0001493152-26-036256 · Items 1.01,7.01,9.01

  6. 4 · Ownership change

    Report date 2026-06-18 · 0001493152-26-029659

  7. 4 · Ownership change

    Report date 2026-06-18 · 0001493152-26-029658

  8. 4 · Ownership change

    Report date 2026-06-18 · 0001493152-26-029657

  9. 8-K · Current report

    Report date 2026-06-18 · 0001493152-26-029486 · Items 5.07

  10. 8-K · Current report

    Report date 2026-06-03 · 0001493152-26-026983 · Items 7.01,9.01

  11. 4 · Ownership change

    Report date 2026-05-18 · 0001493152-26-024342

  12. 4 · Ownership change

    Report date 2026-05-18 · 0001493152-26-024341

  13. 4 · Ownership change

    Report date 2026-05-15 · 0001493152-26-024208

  14. 4 · Ownership change

    Report date 2026-05-14 · 0001493152-26-023321

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001493152-26-022254

  16. 8-K · Current report

    Report date 2026-05-11 · 0001493152-26-022227 · Items 2.02,7.01,9.01

  17. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0001493152-26-018912

  18. 8-K · Current report

    Report date 2026-03-24 · 0001493152-26-013199 · Items 1.01,2.03,8.01,9.01

  19. 8-K · Current report

    Report date 2026-03-24 · 0001493152-26-012389 · Items 8.01,9.01

  20. 8-K · Current report

    Report date 2026-03-24 · 0001493152-26-012279 · Items 8.01,9.01

  21. 8-K · Current report

    Report date 2026-03-10 · 0001493152-26-009452 · Items 7.01,9.01

  22. 10-K · Annual report

    Report date 2025-12-31 · 0001493152-26-008562

  23. 8-K · Current report

    Report date 2026-03-02 · 0001493152-26-008552 · Items 2.02,7.01,9.01

  24. 8-K · Current report

    Report date 2026-01-30 · 0001493152-26-004635 · Items 2.02,5.02,9.01

  25. 8-K · Current report

    Report date 2025-11-17 · 0001493152-25-023988 · Items 2.01,3.02,8.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001493152-25-021562

  27. 8-K · Current report

    Report date 2025-08-11 · 0001493152-25-021555 · Items 2.02,7.01,9.01

  28. 8-K · Current report

    Report date 2025-10-06 · 0001493152-25-017007 · Items 5.02,7.01,9.01

  29. 8-K/A · Current report

    Report date 2025-09-24 · 0001493152-25-016473 · Items 9.01

  30. 8-K · Current report

    Report date 2025-09-26 · 0001493152-25-015878 · Items 1.01,2.03,9.01

  31. 8-K · Current report

    Report date 2025-09-26 · 0001493152-25-015712 · Items 7.01,9.01

  32. 8-K · Current report

    Report date 2025-09-24 · 0001493152-25-015054 · Items 1.01,3.02,8.01,9.01

  33. 8-K · Current report

    Report date 2025-09-17 · 0001493152-25-014242 · Items 4.01,9.01

  34. 8-K · Current report

    Report date 2025-09-08 · 0001493152-25-013268 · Items 1.01,2.03,8.01,9.01

  35. 8-K · Current report

    Report date 2025-09-08 · 0001493152-25-012840 · Items 8.01,9.01

  36. 8-K · Current report

    Report date 2025-09-05 · 0001493152-25-012778 · Items 1.01,2.03,8.01,9.01

  37. 8-K · Current report

    Report date 2025-08-21 · 0001641172-25-025336 · Items 5.02,5.03,9.01

  38. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001641172-25-022980

  39. 8-K · Current report

    Report date 2025-08-11 · 0001641172-25-022971 · Items 2.02,7.01,9.01

  40. 8-K · Current report

    Report date 2025-07-17 · 0001641172-25-019976 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 4 transaction rows4PSale: 0 transaction rows0SGrant / award: 4 transaction rows4AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

8 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-18
2026-06-22
Sternberg Perry J.A · Grant / award
Acquired
RSU
Derivative security
5248.00.0
2026-06-18
2026-06-22
SILVERNAIL LAUREN PA · Grant / award
Acquired
RSU
Derivative security
5248.00.0
2026-06-18
2026-06-22
Graves Adrienne LA · Grant / award
Acquired
RSU
Derivative security
5248.00.0
2026-05-18
2026-05-19
Graves Adrienne LP · Purchase
Acquired
Common Stock1000.031.07
2026-05-18
2026-05-19
SILVERNAIL LAUREN PP · Purchase
Acquired
Common Stock1000.031.0
2026-05-15
2026-05-18
Shojaei AmirA · Grant / award
Acquired
Restricted Stock Units
Derivative security
10000.00.0
2026-05-14
2026-05-15
BAUM MARK LP · Purchase
Acquired
Common Stock10000.030.2
2026-05-14
2026-05-15
BOLL ANDREW R.P · Purchase
Acquired
Common Stock3500.029.9

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001360214HARROW, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Harrow Health · alias · wikidata
  • Imprimis Pharmaceuticals · alias · wikidata
  • HARROW HEALTH, INC. · former SEC name · 2018-12-31 to 2023-09-20
  • Imprimis Pharmaceuticals, Inc. · former SEC name · 2012-03-27 to 2018-12-17
  • TRANSDEL PHARMACEUTICALS INC · former SEC name · 2007-09-13 to 2012-02-27
  • Bywater Resources, Inc · former SEC name · 2006-07-21 to 2007-09-12
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$199.61M$212.48M
2023-12-31$130.19M$142.67M
2022-12-31$88.59M$101.07M
2021-12-31$72.48M$89.30M
2020-12-31$48.87M$63.05M
2019-12-31$51.16M$66.82M
2018-12-31$41.37M$55.01M
2017-12-31$26.77M$36.47M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗